Daisy Genomics is an medtech focused on developing its proprietary long-read DNA sequencing technology for precision medicine applications.
Daisy Genomics has raised $2.5M in total funding. The most recent round was Seed. The last funding was announced in December 2025.
Daisy Genomics's investors include Cottonwood Technology Fund, Sun Mountain Capital, New Mexico Vintage Fund, Waves Capital Partners, Hamamatsu Photonics.
Daisy Genomics is headquartered in Carlsbad, United States.
Daisy Genomics is an medtech focused on developing its proprietary long-read DNA sequencing technology for precision medicine applications.
Daisy Genomics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Daisy Genomics — Funding & Investors." VCBacked, December 17, 2025, https://www.vcbacked.co/company/daisy-genomics. Accessed September 15, 2026.
VCBacked. (2025). Daisy Genomics — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/daisy-genomics
{{cite web |title=Daisy Genomics — Funding & Investors |url=https://www.vcbacked.co/company/daisy-genomics |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated